ID

22332

Descrizione

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

collegamento

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Keywords

  1. 30/05/17 30/05/17 -
Caricato su

30 maggio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Pregnancy Information
Descrizione

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
Descrizione

Pregnancy

Tipo di dati

integer

Alias
UMLS CUI [1]
C0032961
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
Descrizione

Female of childbearing potential

Tipo di dati

integer

Alias
UMLS CUI [1]
C1960468
Study Conclusion
Descrizione

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Did the patient complete the study as planned?
Descrizione

Study completion

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826674
If "no", mark the one most appropriate category
Descrizione

Specification

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348235
Please specify "Other"
Descrizione

Other diseases

Tipo di dati

text

Alias
UMLS CUI [1]
C2359476
Comments on reason for withdrawal:
Descrizione

Withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
Date of Withdrawal
Descrizione

Date of Withdrawal

Tipo di dati

date

Unità di misura
  • dd/mm/yyyy
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
dd/mm/yyyy
Time of Withdrawal
Descrizione

Time of Withdrawal

Tipo di dati

time

Unità di misura
  • hr:min
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0040223
hr:min
Date of Final Dose:
Descrizione

therapy end date

Tipo di dati

date

Unità di misura
  • dd/mm/yyyy
Alias
UMLS CUI [1]
C1531784
dd/mm/yyyy
Time of Final Dose
Descrizione

Pharmaceutical Preparations

Tipo di dati

time

Unità di misura
  • hr:min
Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1522314
hr:min

Similar models

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
integer
C0032961 (UMLS CUI [1])
Code List
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
CL Item
Not applicable (not of childbearing potential) (1)
CL Item
No (2)
CL Item
Yes (3)
Item
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
integer
C1960468 (UMLS CUI [1])
Code List
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
CL Item
Not applicable (subject is female, female partner not of childbearing potential or female partner) (1)
CL Item
No (2)
CL Item
Yes (3)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Study completion
Item
Did the patient complete the study as planned?
boolean
C2826674 (UMLS CUI [1])
Item
If "no", mark the one most appropriate category
integer
C2348235 (UMLS CUI [1])
Code List
If "no", mark the one most appropriate category
CL Item
Adverse Event (complete Adverse Event Form) (1)
CL Item
Insufficient therapeutic effect (2)
CL Item
Deviation from Protocol (including non-compliance) (3)
CL Item
Lost to Follow-Up (4)
CL Item
Other (5)
Other diseases
Item
Please specify "Other"
text
C2359476 (UMLS CUI [1])
Withdrawal
Item
Comments on reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Date of Withdrawal
Item
Date of Withdrawal
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Withdrawal
Item
Time of Withdrawal
time
C2349954 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
therapy end date
Item
Date of Final Dose:
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
Time of Final Dose
time
C0013227 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial